openPR Logo
Press release

First worldwide commercial DNA Test for H5N1 and H9 to detect avian influenza virus

12-07-2005 10:28 AM CET | Health & Medicine

Press release from: Genekam Biotechnology AG

Genekam Bird flu DNA-Test (H5N1, H9)

Duisburg, December 7th, 2005

With help of modern technology, German’s molecular medicine company Genekam did a good job on developing a most reliable and accurate DNA-based test that is able to detect the avian influenza virus H5N1 along with the not less dangerous H9 virus in a very short time. This DNA test is not only reliable and most accurate. It can be performed under field conditions. Till today such tests were not available on the market.

Already again, newspapers said early this week, that a 9 year old boy laid up with an avian influenza infection for the first time in China. Chinese’s government did not yet confirm whether it is the dangerous virus known as bird flu. The only reason is that the authorities used tests based on antibodies called serological or rapid-test. But all these serological tests are inaccurate and may lead to cross reactions, hence may give false positive and leading to false alarms. The verification of this case is usually done through a special laboratory, which needs many days to confirm the results i.e. a waste of precious time that would have better been used for preventive measures. Genekam gives latest technological weapon i.e. DNA test to fight the bird flu virus under field conditions.

With Genekam’s latest developed test the result is available within seven hours, which are most precise and accurate. Moreover this DNA-test is not only available for special labs but may also be performed by the smallest laboratories throughout the world for a reasonable price. The recognition of the avian influenza virus in China would have been possible in an earlier stage using Genekam’s bird flu test. Similarly such false alarm raised through Greece would have been avoided, if the Greece laboratories would have used the Genekam DNA tests. Moreover public panic can be avoid through only most accurate tests rather using unreliable serological tests, which can cause of a lot of economical losses through panic.
This particular test is based on the PCR-method (polymerase chain reaction). It can be used to detect a latent and symptom less infection (e.g. migratory birds) in human as well as animals, so preventive measures can be ordered immediately. The serological or rapid tests are not able to detect such symptom less carries. Earlier detection can be also only through DNA test. Earlier you detect the case, earlier , one can start with the preventive measurement.

Everybody can take the services for testing of bird flu of Genekam regardless where he is located on this planet. Moreover there are many international companies having their employees as well as foreign diplomat working in bird flu endangered areas. Many international companies have bought a lot of antiviral drugs to use them for their employees in these areas as this is not a good idea because you have to give the antiviral medicine to the suffering persons, hence therefore DNA testing of employees is a must before using these antiviral drugs. In case the DNA test says that a person is positive for bird flu, then you can start with antiviral therapy. It is very easy to get this test done as Genekam needs only 0.5 ml of blood and it can be posted through currier easily. Similarly people travelling the bird flu endangered areas can get themselves checked through the Genekam DNA tests. At the same time Companies importing poultry meat, fast-food as well as food superstores should regularly get their poultry meat checked for bird flu, just by sending one gram of meat to Genekam laboratory. The cost per test is only Euro 49,- (in case of positive samples, it will be Euro 129 because one needs gene sequencing to give the final results).
We think that Genekam DNA tests will help a lot people in many countries, which are searching for reliable and accurate DNA tests to run the preventive measurements. We hope that they will be able to replace old and not reliable serological tests like car has replaced the bicycle to cover the distance.
Genekam Biotechnology AG, developing and distributing about 120 DNA tests so far, is at present engaged in researching to develop a test for detecting the virus H7.
With Genekam’s latest DNA-test the avian influenza virus can be verified successfully. It is a milestone in the history of molecular medicine. as prevention is the best medicine.




Genekam Biotechnology AG | A molecular medicine company
Dammstraße 31-33, 47119 Duisburg
Telefon (0203) 55 58 58-31 Telefax (0203) 35 82 99
eMail: anfrage@genekam.de Website: www.genekam.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release First worldwide commercial DNA Test for H5N1 and H9 to detect avian influenza virus here

News-ID: 792 • Views:

More Releases from Genekam Biotechnology AG

World Innovation: First therapeutic molecule candidate against Zika viruses
World Innovation: First therapeutic molecule candidate against Zika viruses
Genekam Biotechnology AG, which developed the first test for Zikavrius detection in Januar 2016, has developed as one of first company in the world the therapeutic molecule candidate for Zika viruses, which is likely to be the first potential candidate for Zika-virus therapy. Zika viruses are known to cause fears as they infect pregnant women leading to disorders and new born with microencephaly (child with smaller head) with whole life handicap
DNA-FluHunter - The all-rounder weapon against bird flu virus
First commercial DNA-Test worldwide to detect all pathogenic strains of bird flu H5, N1, H9 and H7. Duisburg, July 31 2007: Genekam Biotechnology AG has now developed the first commercial DNA-Test of the world to detect all dangerous types of bird flu H5, N1, H7, H9. These stocks lead to disease and death in both human and animals. Especially H5 and H7 are aggressive to birds, leading to mortality and economical
DNA Fluhunter - First commercial DNA-Test worldwide to detects all pathogenic st …
Duisburg 22. Dezember 2005 Genekam Biotechnology AG has now developed the first commercial DNA-Test of the world to detect all dangerous types of bird flu H5, N1, H7, H9. These stocks lead to disease and death in both human and animals. Especially H5 and H7 are aggressive to birds, leading to mortality and economical losses in a short time. DNA-tests have the particular feature to be most reliable, accurate

All 4 Releases


More Releases for DNA

High-Quality Plasmid DNA Fuels Growth in Global DNA Plasmid Manufacturing Market
🌍 Market Overview The DNA Plasmid Manufacturing Market is experiencing robust growth as advancements in cell & gene therapy, DNA vaccines, and genetic engineering continue to expand globally. Plasmid DNA plays a critical role as a raw material in the development of advanced therapies, fueling demand across biopharmaceutical research and production. Key factors driving the market include: Increasing adoption of gene and cell therapies Rising prevalence of chronic and rare genetic disorders Expansion of DNA-based
DNA Synthesis Market Increasing Demand for Synthetic Genes and DNA Sequences
As demonstrated by Precision Business Insights (PBI), the latest report, the global DNA synthesis market was valued at USD 3,702.0 million in 2023 and is expected to reach USD 10,289.5 million by 2029, growing at a CAGR of 18.6% during the forecast period 2024-2030. The key drivers for the growth of the global DNA synthesis market include increasing demand for synthetic genes and DNA sequences, growing applications in the agriculture
Wealth DNA Code Review Legit Price? (Wealth Manifestation DNA Code Audio Frequen …
Wealth DNA Code Wealth DNA Code is a digital program with seven minutes of soundtracks that manifest and listen to daily to activate the "Wealth DNA," which is part of your DNA to help you attract wealth by making money a part of your mentality and making your dreams to come true. https://bit.ly/Visit-The-Official-Website-Here-To-Order-Wealth-DNA-Code Making money, creating assets as well as increasing wealth are the primary objectives that every human being has to
DNA Paternity Testing Market Size [2022-2029] -DNA Diagnostics Center, EasyDNA, …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global DNA Paternity Testing. On the basis of historic growth analysis and current scenario of DNA Paternity Testing place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent
DNA Paternity Testing Market Trends 2020 | Growth by Top Companies: DNA Diagnost …
The report begins with the overview of the DNA Paternity Testing Market and offers throughout development. It presents a comprehensive analysis of all the regional and major player segments that gives closer insights upon present market conditions and future market opportunities along with drivers, trending segments, consumer behaviour, pricing factors and market performance and estimation. The forecast market information, SWOT analysis, DNA Paternity Testing market scenario, and feasibility study are
DNA Paternity Testing Market Rapidly Growing in Healthcare, Competitor Analysis …
The exclusive research report on the Global DNA Paternity Testing Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global DNA Paternity Testing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. Overview of Global DNA Paternity Testing Market: This report studies the Global DNA Paternity Testing